GOMOSDI FUSA
Live / Applied — First extension granted (statement of use) (as of 04 Mar 2026)
What this means for you
Not registered yet, but its 24 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98818002
- Mark type
- Stylized text
- Filed
- 24 Oct 2024
- Published for opposition
- 29 Apr 2025
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases
Owner
- TEVA PHARMACEUTICALS USA, Inc., Parsippany, NJ, US
- TEVA PHARMACEUTICALS USA, Inc., Parsippany, NJ, US
Prosecution history
- 04 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2026 — SOU EXTENSION 1 GRANTED
- 23 Dec 2025 — SOU EXTENSION 1 FILED
- 02 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Jan 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 26 Jan 2026 — NOTICE OF REVIVAL - E-MAILED
- 26 Jan 2026 — PETITION TO REVIVE-GRANTED
- 26 Jan 2026 — TEAS PETITION TO REVIVE RECEIVED
- 26 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 21 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED